Overcoming barriers to green chemistry in the pharmaceutical industry-the Green Aspiration Level™ concept

Green Chemistry

Volumn 17, Issue 2, 2015, Pages 752-768

  Roschangar, F ^a   Sheldon, R A ^b   Senanayake, C H ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922820706     PISSN: 14639262     EISSN: 14639270     Source Type: Journal    
DOI: 10.1039/c4gc01563k     Document Type: Review

References (76)

1. R. Noyori Synthesizing Our Future Nat. Chem. 2009 1 5 6
2. P. J. Dunn, A. S. Wells and M. T. Williams, Green Chemistry in the Pharmaceutical Industry, Wiley-VCH, 2010
3. P. T. Anastas and J. C. Warner, Green Chemistry-Theory and Practice, Oxford University, 2000
4. P. T. Anastas, Handbook of Green Chemistry, John Wiley and Sons, 2012
5. J. Clark and D. MacQuarrie, Handbook of Green Chemistry and Technology, Blackwell Science, 2002
6. M. Lancaster, Green Chemistry: An Introductory Text, The Royal Society of Chemistry, 2010
7. P. Tundo, F. Aricò and C. R. McElroy, The Chemical Element-6. The Greening of Chemistry, ed., J. Garcia-Martinez, and, E. Serrano-Torregrosa, Wiley-VCH, 2011, pp. 189-234
8. S. K. Sharma and A. Mudhoo, Green Chemistry for Environmental Sustainability, CRC Press, 2011
9. P. T. Anastas and J. B. Zimmerman, Innovations in Green Chemistry and Green Engineering, Springer, 2013
10. P. B. Joshi Green Metrics in a Pharmaceutical Scenario-a Review J. Pharm. Bioanal. Sci. 2013 2 39 46
11. M. Kennet, Introduction to Green Economics, Harvard School Economics Review, 2008
12. K. J. M. Matus E. C. Clark P. T. Anastas J. B. Zimmerman Barriers to the Implementation of Green Chemistry in the United States Environ. Sci. Technol. 2012 46 10892 10899
13. M. Poliakoff P. Licence Sustainable Technology: Green Chemistry Nature 2007 450 810 812
14. M. Poliakoff J. M. Fitzpatrick T. R. Farren P. T. Anastas Green Chemistry: Science and Politics of Change Science 2002 297 807 810
15. M. A. Abraham et al., Overcoming Nontechnical Barriers to the Implementation of Sustainable Solutions in Industry Environ. Sci. Technol. 2009 43 4221 4226
16. M. P. Wilson M. R. Schwarzman Toward a New US Chemicals Policy: Rebuilding the Foundation to Advance New Science, Green Chemistry, and Environmental Health Environ. Health Perspect. 2009 117 1202 1209
17. K. J. M. Matus X. Xiao J. B. Zimmerman Green Chemistry and Green Engineering in China: Drivers, Policies and Barriers to Innovation J. Cleaner Prod. 2012 32 193 203
18. D. K. Leahy et al., Seven Important Elements for an Effective Green Chemistry Program: An IQ Consortium Perspective Org. Process Res. Dev. 2013 17 1099 1109
19. U.S. FDA Q11 Development and Manufacture of Drug Substance, 2012. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM261078.pdf
20. U.S. FDA Guideline for Submitting Supporting Documentation in Drug Applications for the Manufacture of Drug Substances, 1987. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070632.pdf
21. U.S. FDA Changes to an Approved NDA or ANDA, 2004. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm077097.pdf
22. J. A. Vernon J. H. Golec J. A. DiMasi Drug Development Costs When Financial Risk is Measured Using the Fama-French Three Factor Model Health Econ. 2010 19 1002 1005
23. J. A. DiMasi H. G. Grabowski The Cost of Biopharmaceutical R&D: Is Biotech Different? Managerial & Decision Economics 2007 28 469 479
24. S. M. Paul et al., How to Improve R&D Productivity: the Pharmaceutical Industry's Grand Challenge Nat. Rev. Drug Discovery 2010 9 203 214
25. In 2010, the IQ Green Chemistry working group of the IQ Consortium was chartered to "drive innovation and the awareness of green chemistry in pharmaceutical development through the establishment and adoption of best practices, sharing of information within peer networks, and collaboration with regulatory agencies and other key stakeholders. http://iqconsortium.org/initiatives/working-groups/green-chemistry/
26. S. K. Ritter Process Chemistry: Recasting Regulatory Strategies to Enable Green Chemistry Chem. Eng. News 2014 92 March 24 32 33
27. D. Meadows, Indicators and Information Systems for Sustainable Development, The Sustainability Institute, 1998
28. N. Hawker, The Business Case for Green & Sustainable Chemistry, Ecochem-The Sustainable Chemistry & Engineering Platform, 2009
29. E. J. Corey and X.-M. Cheng, The Logic of Chemical Synthesis, Wiley, 1989
30. E. J. Corey W. J. Howe H. W. Orf D. A. Pensak G. Petersson General Methods of Synthetic Analysis-Strategic Bond Disconnections for Bridged Polycyclic Structures J. Am. Chem. Soc. 1975 97 6116 6124
31. B. M. Trost The Atom Economy-a Search for Synthetic Efficiency Science 1991 254 1471 1477
32. B. M. Trost Atom Economy. A Challenge for Organic Synthesis: Homogeneous Catalysis Leads the Way Angew. Chem., Int. Ed. 1995 34 259 281
33. R. A. Sheldon Organic synthesis; past, present and future Chem. Ind. 1992 903 906
34. R. A. Sheldon, Green Chemistry-The E factor. http://www.sheldon.nl/roger/efactor.html
35. R. A. Sheldon The E factor: fifteen years on Green Chem. 2007 9 1273 1283
36. R. A. Sheldon Consider the environmental quotient. Chem. Technol. 1994 24 38 47
37. R. A. Sheldon Catalysis: The Key to Waste Minimization J. Chem. Technol. Biotechnol. 1997 68 381 388
38. R. A. Sheldon Atom Efficiency and Catalysis in Organic Synthesis Pure Appl. Chem. 2000 72 1233 1246
39. R. A. Sheldon Catalysis and Pollution Prevention Chem. Ind. 1997 12 15
40. EPA Green Chemistry-1998 Academic Award. http://www2.epa.gov/green-chemistry/1998-academic-award-trost
41. A. D. Curzons D. J. C. Constable D. N. Mortimer V. L. Cunningham So You Think Your Process is Green, How do You Know? - Using Principles of Sustainability to Determine What is Green-a Corporate Perspective Green Chem. 2001 3 1 6
42. G. R. Geen et al., Green Chemistry Measures for Process Research and Development Green Chem. 2001 3 7 9
43. D. J. C. Constable A. D. Curzons V. L. Cunningham Metrics to 'Green' Chemistry - Which are Best? Green Chem. 2002 3 521 527
44. A. Lapkin and D. Constable, Green Chemistry Metrics-Measuring and Monitoring Sustainable Processes, Wiley-Blackwell, 2008
45. G. W. Huisman R. A. Sheldon et al., A Green-By-Design Biocatalytic Process for Atorvastatin Intermediate Green Chem. 2010 12 81 86
46. R. K. Henderson, J. Kindervater and J. B. Manley, Lessons Learned Through Measuring Green Chemistry Performance-The Pharmaceutical Experience, 2007. http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/roundtable/lessons-learned-through-measuring-green-chemistry-performance-the-pharmaceutical-experience.pdf
47. According to the WHO, the ten largest drug companies control over one third of the global pharmaceuticals market, estimated at $300-400 billion per year, with profit margins in the neighborhood of 30%. http://www.who.int/trade/glossary/story073/en/
48. D. Hughes, Pharma and Suppliers: Collaborating on Green Chemistry. Launch of the PMI tool, 2011. http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/gcipr-informex-2011-pmi-tool.pdf
49. C. Jimenez-Gonzalez C. S. Ponder Q. B. Broxterman J. B. Manley Using the Right Green Yardstick: Why Process Mass Intensity Is Used in the Pharmaceutical Industry to Drive More Sustainable Processes Org. Process Res. Dev. 2011 15 912 917
50. ACS GCI Pharmaceutical Roundtable presentation "Convergent PMI Calculator", 2014. http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/roundtable/Convergent-PMI-Presentation.pptx
51. U.S. manufacturing site-specific waste data are available from the online Toxic Release Inventory (TRI) industry sector reports published by The Center for Effective Government. Accordingly, 25% of pharmaceutical waste was recycled, 38% burnt for energy recovery, and 36% was treated in 2012. http://www.rtknet.org/db/tri/about
52. S. M. Paul et al., How to Improve R&D Productivity: the Pharmaceutical Industry's Grand Challenge Nat. Rev. Drug Discovery 2010 9 203 214
53. PharmaLive.com Global Contract Manufacturing Companies: Pharmaceutical and Biotechnology, 2011. http://www.paragonbioservices.com/LinkClick.aspx?fileticket=a4tkUko4CZo=
54. G. Roth, Annual Outsourcing Survey, 2013. http://www.contractpharma.com/issues/2013-05/view-outsourcing-survey/2013-annual-outsourcing-survey/
55. Sigma-Aldrich's U.S. website: http://www.sigmaaldrich.com/united-states.html
56. J. S. Carey D. Laffan C. Thomson M. T. Williams Org. Biomol. Chem. 2006 4 2337 2347
57. D. P. Kjell I. A. Watson C. N. Wolfe J. T. Spitler Complexity-Based Metric for Process Mass Intensity in the Pharmaceutical Industry Org. Process Res. Dev. 2013 17 169 174
58. J. B. Hendrickson Systematic Synthesis Design. IV. Numerical Codification of Construction Reactions J. Am. Chem. Soc. 1975 97 5784 5800
59. P. A. Wender and B. L. Miller, Organic Synthesis: Theory and Applications, ed., T. Hudlicky, JAI Press, 1993, vol. 2, pp. 27-66
60. T. Newhouse P. S. Baran R. W. Hoffmann The Economies of Synthesis Chem. Soc. Rev. 2009 38 3010 3021
61. P. A. Wender M. P. Croatt B. Witulski New Reactions and Step Economy: the Total Synthesis of (+/-)-Salsolene Oxide Based on the Type II Transition Metal-Catalyzed Intramolecular [4 + 4] Cycloaddition Tetrahedron 2006 62 7505 7511
62. P. A. Wender V. A. Verma T. J. Paxton T. H. Pillow Function Oriented Synthesis, Step Economy, and Drug Design Acc. Chem. Res. 2008 41 40 49
63. P. A. Wender B. L. Miller Synthesis at the Molecular Frontier Nature 2009 460 197 201
64. P. S. Baran et al., Enantiospecific Total Synthesis of the Hapalindoles, Fischerindoles, and Welwitindolinones via a Redox Economic Approach J. Am. Chem. Soc. 2008 130 17938 17954
65. N. Z. Burns P. S. Baran R. W. Hoffmann Redox Economy in Organic Synthesis Angew. Chem., Int. Ed. 2009 48 2854 2867
66. T. Gaich P. S. Baran Aiming for the Ideal Synthesis J. Org. Chem. 2010 75 4657 4673
67. M. E. Kopach, The Use of Electronic Lab Notebook (ELN) for Green Science at Eli Lilly and Company. Presentation at Great Lakes Regional Pollution Prevention Roundtable, Indianapolis, Illinois, USA, 2009
68. M. E. Kopach E. A. Reiff Use of the Electronic Laboratory Notebook to Facilitate Green Chemistry Within the Pharmaceutical Industry Fut. Med. Chem. 2012 11 1395 1398
69. See 'Awards and Recognition' section available on Pfizer's website: http://www.pfizer.com/responsibility/protecting-environment/greener-processes
70. P. J. Dunn et al., The Chemical Development of the Commercial Route to Sildenafil: A Case History Org. Process Res. Dev. 2000 4 17 22
71. P. J. Dunn S. Galvin K. Hettenbach The Development of an Environmentally Benign Synthesis of Sildenafil Citrate (Viagra™) and Its Assessment by Green Chemistry Metrics Green Chem. 2004 6 43 48
72. A. S. Bell, D. Brown and N. K. Terrett, Pyrazolopyrimidinone Antianginal Agents, European Patent Application, EP 0463756 A1, 1992
73. M. Kopp J.-C. Lancelot P. Dallemagne S. Rault Synthesis of Novel Pyrazolopyrrolopyrazines, Potential Analogs of Sildenafil J. Heterocycl. Chem. 2001 38 1045 1050
74. T. G. Gant and S. Sarshar, Highly Selective and Long-Acting PDE5 Modulators, U.S. Patent Application, US20080194529A1, 2008
75. P. J. Dunn Pharmaceutical Green Chemistry Process Changes-How Long Does it Take to Obtain Regulatory Approval? Green Chem. 2013 15 3099 3104
76. PNM blog, Ford Motor Company: "Best Ethics Management System" http://nmfaltis.wordpress.com/2010/03/30/ford-motor-company-%E2%80%9Cbest-ethics-management-system%E2%80%9D/